GLP-1 Weight-Loss Plateaus: Why They Happen and What to Do Next admin November 13, 2026
favicon
DR. RAVI RAO

Weight Loss Surgeon

glp-1 weight-loss plateaus

GLP-1 Weight-Loss Plateaus: Why They Happen and What to Do Next

Why Does Weight Loss Slow Down on GLP-1 Medications?

You have been taking a GLP-1 medication, your appetite has settled, and the first months went well. Then the scale stops moving. You may wonder: Has the medication stopped working? Have I done something wrong? Should I change my dose?

A plateau can be frustrating, but it is a common part of weight management. Weight loss often slows over time because the body adapts as weight decreases, and the right next step depends on your individual circumstances.

Why does weight loss slow down on GLP-1 medications?

Early weight loss can be faster because your body is responding to a new treatment and a reduced energy intake. As your weight falls, your body may increase hunger signals and reduce signals of fullness and energy sufficiency. This is sometimes called metabolic adaptation.

At the same time, a smaller body generally requires less energy to maintain itself. So, the amount you eat may more closely match the amount your body uses, which can make further weight change slower.

A plateau does not necessarily mean the medication has failed. In clinical practice, weight loss with GLP-1 medications often follows a pattern of early loss, gradual slowing and eventual stabilisation.  

When is it a true plateau?

There is no single definition that applies to every patient. Some clinicians consider a plateau when weight has changed very little over several weeks, while others look for a longer period of little or no change before reviewing treatment.

The more important question is not only what the scale says. Your clinician will consider whether you are still meeting your health goals, whether symptoms have improved, and whether the plateau is affecting your physical function or wellbeing.

What should you review with your clinician?

Before changing treatment, a structured review can identify practical reasons for a stall. These may include:

  • Medication use: Missed doses, incorrect storage, or a dose that has not yet been optimised can affect response.
  • Side effects: Nausea, reflux, constipation, or reduced food intake may need medical and dietetic support.
  • Nutrition: Appetite changes can make it difficult to maintain adequate nutrition. A dietitian can assess your intake without applying one universal protein, fluid, or meal-frequency target.
  • Activity and strength: Movement and resistance-based exercise may support body composition and function during weight loss, but the right programme should suit your health, ability, and preferences.
  • Sleep and stress: Poor sleep and ongoing stress can influence appetite, food choices, and adherence.
  • Medical factors: Conditions such as thyroid disease, menopause-related changes, medications, and other chronic conditions may affect weight regulation and should be assessed by your treating team.  

Should you change your dose?

Do not increase, reduce, stop or switch a GLP-1 medication on your own. Dose decisions should be made with your prescribing clinician, based on your response, side effects, medical history and treatment goals.

Depending on your situation, your clinician may allow more time at your current dose, review how you are taking the medication, adjust the dose within the approved range, or consider other treatment options. If side effects are limiting treatment, a lower dose or a different approach may be more appropriate than pushing through discomfort.  

What about nutrition and body composition?

Weight loss can include both fat mass and fat-free mass. Research suggests that GLP-1 receptor agonists often reduce fat mass more than lean mass, but absolute reductions in lean mass can still occur.

Lean mass is not the same as skeletal muscle. It includes water, organs, connective tissue, bone and other non-fat tissues, so body-composition results should be interpreted carefully by a qualified clinician.

If you are concerned about strength, fatigue, or excessive loss of fat-free mass, your team may consider nutrition review, physical-activity advice and, where appropriate, body-composition assessment. Any supplement or meal-replacement recommendation should be individualised rather than assumed to be necessary for everyone.

When should you seek help sooner?

Contact your prescribing clinician sooner if you have severe or persistent vomiting, signs of dehydration, significant constipation, abdominal pain, dizziness, rapid weight loss, or difficulty maintaining adequate food and fluid intake.

You should also seek review if the plateau is causing distress, if you are unsure whether your medication is being used correctly, or if you are considering stopping treatment. A specialist-led, multidisciplinary team can assess the full picture rather than relying on the scale alone.

What can you do next?

A sensible next step is to schedule a review rather than making sudden changes. Keep a record of your weight trends, medication use, symptoms, meals, activity levels, sleep, and any side effects to help guide the discussion. Your care team can assess whether you need more time, nutritional support, a medication review, guidance from a dietitian or exercise professional, or further investigation into other contributing factors. Ultimately, the focus should go beyond weight loss alone to achieving lasting improvements in metabolic health, body composition, and physical function, while maintaining a healthy and sustainable weight.

References

https://www.nature.com/articles/s41366-026-02118-y?error=cookies_not_supported&code=8765caed-88b2-4a42-b34c-e14d090a5ecf

Related

Write a comment
Your email address will not be published. Required fields are marked *